Boiron SA (FR:BOI)

:BOI

BOI

Boiron SA

RESEARCH TOOLSreports

Want to see FR:BOI full AI Analyst Report?

Boiron SA (BOI) Price & Analysis

6 Followers

BOI Stock Chart & Stats

€30.40

-€0.10(-0.37%)

At close: Jan 08 4:00 PM EST

€30.40

-€0.10(-0.37%)

Day’s Range― - ―

52-Week Range€20.85 - €32.25

Previous CloseN/A

Volume116.00

Average Volume (3M)4.19K

Market Cap

€471.25M

Enterprise Value€419.19M

Total Cash (Recent Filing)€79.34M

Total Debt (Recent Filing)€31.48M

Price to Earnings (P/E)6.3

Beta0.19

Next Earnings

Sep 09, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend Yield3.95%

Share Statistics

EPS (TTM)1.86

Shares Outstanding17,545,408

10 Day Avg. Volume1,557

30 Day Avg. Volume4,187

Financial Highlights & Ratios

PEG Ratio0.09

Price to Book (P/B)1.35

Price to Sales (P/S)1.06

P/FCF Ratio17.89

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price TargetN/A

Price Target UpsideN/A

Rating ConsensusN/A

Number of Analyst Covering0

EPS Forecast (FY)2.06

Revenue Forecast (FY)€522.30M

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet, Low LeverageSustained low leverage provides durable financial flexibility: it supports dividend policy, funds working capital, and cushions the business during demand shocks. A conservative balance sheet reduces refinancing risk and permits opportunistic investment without heavy interest burdens.

Improved Margins And Recovering ReturnsHigher net margin and rebounding ROE indicate improved operating efficiency and profitability sustainability. Persistently better margins underpin cash generation and make the core OTC/homeopathic business more resilient to modest revenue swings over the medium term.

Branded OTC Business With Pharmacy DistributionAn established branded-OTC model with pharmacy distribution and international reach supports recurring demand, pricing control, and channel access. These structural attributes help maintain revenue streams and customer familiarity versus commodity generics over multiple quarters.

Bears Say

Severe 2025 Revenue Contraction And Choppy SalesA pronounced revenue collapse in 2025 and generally choppy top-line trends materially reduce earnings visibility and planning horizons. Persistent sales volatility can erode scale advantages, complicate inventory and supply decisions, and force margin trade-offs over the medium term.

Volatile Free Cash Flow With Sharp 2025 DeclineIrregular free cash flow undermines predictable funding for reinvestment, dividends, and buybacks. A sharp FCF drop in 2025 signals weaker cash conversion and raises reliance on balance sheet buffers; this reduces capacity for consistent strategic investment and increases uncertainty.

Declining Equity And Asset BaseA shrinking equity and asset base diminishes the company’s margin for error and its ability to scale operations. Reduced asset levels can limit commercial reach and underwriting of investment, making it harder to absorb future shocks or fund organic growth without external financing.

BOI FAQ

What was Boiron SA’s price range in the past 12 months?

Boiron SA lowest stock price was €20.85 and its highest was €32.25 in the past 12 months.

What is Boiron SA’s market cap?

Boiron SA’s market cap is €471.25M.

When is Boiron SA’s upcoming earnings report date?

Boiron SA’s upcoming earnings report date is Sep 09, 2026 which is in 111 days.

How were Boiron SA’s earnings last quarter?

Boiron SA released its earnings results on Mar 18, 2026. The company reported €1.206 earnings per share for the quarter, beating the consensus estimate of N/A by €1.206.

Is Boiron SA overvalued?

According to Wall Street analysts Boiron SA’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Boiron SA pay dividends?

Boiron SA pays a Annually dividend of €1.2 which represents an annual dividend yield of 3.95%. See more information on Boiron SA dividends here

What is Boiron SA’s EPS estimate?

Boiron SA’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Boiron SA have?

Boiron SA has 17,545,408 shares outstanding.

What happened to Boiron SA’s price movement after its last earnings report?

Boiron SA reported an EPS of €1.206 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.58%.

Which hedge fund is a major shareholder of Boiron SA?

Currently, no hedge funds are holding shares in FR:BOI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description

Boiron SA

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.